Supernus, Inc. SEC filings SUPN
Supernus, Inc. has 572 filings in SEC EDGAR's recent list, going back to Dec 2, 2014. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Oct 29, 2026 | — |
| 425 | Filing | Oct 6, 2026 | — |
| 425 | Filing | Sep 17, 2026 | — |
| EFFECT | Filing | Sep 11, 2026 | — |
| 425 | Filing | Aug 4, 2026 | — |
| 425 | Filing | Aug 3, 2026 | — |
| 425 | Filing | Aug 3, 2026 | — |
| 425 | Filing | Aug 3, 2026 | — |
| 425 | Filing | Aug 3, 2026 | — |
| 15-12G | Deregistration | Jan 26, 2026 | — |
| SEC STAFF LETTER | Filing | Jun 12, 2023 | — |
| SEC STAFF ACTION | Filing | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| CERT | 20-f | Jun 7, 2023 | — |
| 20FR12B/A | Filing | Jun 5, 2023 | — |
| CORRESP | Letter to the SEC | May 23, 2023 | — |
| 20FR12B | Filing | May 23, 2023 | — |
| SEC STAFF LETTER | Filing | May 11, 2023 | — |
| UPLOAD | Letter from the SEC | May 9, 2023 | — |
| DRSLTR | Filing | Apr 27, 2023 | — |
| DRS/A | Filing | Apr 27, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2023 | — |
| DRS/A | Filing | Mar 10, 2023 | — |
| DRSLTR | Filing | Mar 9, 2023 | — |
| DFAN14A | Filing | Feb 16, 2023 | — |
| DFAN14A | Filing | Feb 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2023 | — |
| DRSLTR | Filing | Jan 18, 2023 | — |
| DRS/A | Filing | Jan 18, 2023 | — |
| DFAN14A | Filing | Dec 20, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2022 | — |
| DFAN14A | Filing | Dec 7, 2022 | — |
| DRS/A | Filing | Nov 22, 2022 | — |
| DRS | Filing | Nov 22, 2022 | — |
| 20FR12B/A | Filing | Aug 24, 2016 | — |
| 20FR12B/A | Filing | Aug 1, 2016 | — |
| 20FR12B | Filing | Jul 14, 2016 | — |
| EFFECT | Filing | Dec 23, 2014 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INDV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1625297
- Former names
- Indivior Pharmaceuticals, Inc. (until Nov 2, 2026); INDIVIOR PLC (until Jan 8, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.